姓名：王传跃 性别：男 职称：主任医师、教授 招生院所：附属安定医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：精神病与精神卫生学(博) 精神病与精神卫生学(硕) 研究方向名称：精神分裂症的诊断与治疗 电子信箱：wang.cy@163.net


社会任职
1. 《中华精神科杂志》、《中国神经精神疾病杂志》、《上海精神医学》和《临床精神医学杂志》编委，《国际精神病学杂志》和《精神医学杂志》特约编委
2. 北京药理学会理事，北京医师协会精神科专家委员会委员，北京药理学会临床药理专业委员会委员，北京药理学会神经精神药理专业委员会委员，北京药学会药物安全评价委员会委员
3. 中国神经科学学会精神病基础与临床分会常委，中国中西医结合学会精神疾病专业委员会常委，中国药理学会药物基因组学专业委员会委员，中国医师协会神经调控专业委员会委员，中国医疗保健国际交流促进会精神卫生分会委员，中国老年保健协会抗衰老专业委员会委员
个人简历
1. 197810-198310:江西医学院医疗系 本科生
2. 198312-199107:江西省九江市精神病医院 精神科医师、主治医师
3. 199108-199707:湖南医科大学精神卫生研究所 硕士生、博士生
4. 199708-:首都医科大学附属北京安定医院 精神科主治医师、副主任医师、主任医师，精神病学副教授、教授
重要学术论文
1. Liu S, Tian M#, He F#, Li J#, Xie H#, Liu W, Zhang Y, Zhang R, Yi M, Che F, …, Xing J, Wang C*, Yu F*, Guan JS*.Spontaneous hyperactivity in Ash1l mutant mice, a new model for Tourette syndrome. Mol Psychiatry. 2020,25(2):241-242.SCI
2. Liu S, Tian M#, He F#, Li J#, Xie H#, Liu W, Zhang Y, Zhang R, Yi M, Che F, …, Xing J, Wang C*, Yu F*, Guan JS*.Mutations in ASH1L confer susceptibility to Tourette syndrome. Mol Psychiatry. 2020,25(2):476-490.SCI
3. Huang J, Zhou FC#, Guan B, Zhang N, Wang A, Yu P, Zhou L, Wang CY*, Wang C*.Predictors of Remission of Early-Onset Poststroke Depression and the Interaction Between Depression and Cognition During Follow-Up. Front. Psychiatry. 2019,9:738.SCI
4. Bo Q, Dong F#, Li X, Li F, Li P, Yu H, He F, Zhang G, Wang Z, Ma X, Wang C*.A comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls. Psychiatry Clin Neurosci. 2019,73(2):70-76.SCI
5. Wen YJ, Li XB, Zhao XX, Wang XQ, Hou WP, Bo QJ, Zheng W, Pao C, Tan T, Wang CY*.he effect of left-behind phenomenon and physical neglect on behavioral problems of children. Child Abuse Negl. 2019,88:144-151.SCI
6. Xiong YB, Bo QJ, Wang CM, Tian Q, Liu Y, Wang CY*.Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia. Front. Behav. Neurosci. 2019,13:37.SCI
7. Chen S, Tian L, Chen N, Xiu MH, Wang ZR, Wang YC, Tan YL*, Wang CY*.More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia. Schizophrenia Research. 2019,206:300-306.SCI
8. Luo Y, Zhang J*, Wang C, Zhao X, Chang Q, Wang H, Wang C*.Discriminating schizophrenia disease progression using a P50 sensory gating task with dense-array EEG, clinical assessments, and cognitive tests. Expert Rev Neurother. 2019,19(5):459-470.SCI
9. Li XB, Wang LB#, Xiong YB, Bo QJ, He F, Li F, Hou WP, Wen YJ, Wang XQ, Yang NB, Mao Z, Dong QH, Zhang FF, Yang R, Wang D, Xiang YT, Zhu YY, Tang YL, Yang Z, Wang CY*.Altered resting-state functional connectivity of the insula in individuals with clinical high-risk and patients with first-episode schizophrenia. Psychiatry Res. 2019,282:112608.SCI
10. Chen X, Li X#, Yan T, Dong Q, Mao Z, Wang Y, Yang N, Zhang Q, Zhao W, Zhai J, Chen M, Du B, Deng X, Ji F, Xiang YT, Song J, Wu H, Dong Q, Chen C, Wang C*, Li J*.Network functional connectivity analysis in individuals at ultrahigh risk for psychosis and patients with schizophrenia. Psychiatry Res: Neuroimaging. 2019,290:51-57.SCI
11. Chang Q, Liu M, Tian Q, Wang H, Luo Y, Zhang J*, Wang C*.EEG-Based Brain Functional Connectivity in First-Episode Schizophrenia Patients, Ultra-High-Risk Individuals, and Healthy Controls During P50 Suppression. Front Hum Neurosci. 2019,13:379.SCI
12. Li XB, Zheng W#, Ning YP#, Cai DB, Yang XH, Ungvari GS, Ng CH, Wang CY*, Xiang YT*.Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review. Pharmacopsychiatry. 2018,51(3):100-104.SCI
13. Li X, Tian Q, Bo Q, Zhang G, Zheng W, Wen Y, Tang Y, Wang C*.Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia. Psychiatry Res. 2018,263:69-73.SCI
14. Zheng H, Li F, Bo Q, Li X, Yao L, Yao Z, Wang C*, Wu X*.The dynamic characteristics of the anterior cingulate cortex in resting-state fMRI of patients with depression. J Affect Disord. 2018,227:391-397.SCI
15. Bo Q, Mao Z#, Tian Q, Wen Y, Dong F, Li X, Wang Z, Ma X, Wang C*.Deficits of perceived spatial separation-induced prepulse inhibition in patients with bipolar disorder compared to healthy controls. J Affect Disord. 2018,240:63-71.SCI
16. Li A, Ji S#, Yue W, Yan H, Dong F, Ruan C, Li W, Lu W, Zhang D*, Wang C*.Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia. BMJ Open. 2018,8(8):e020070.SCI
17. Li XB, Bo QJ, Tian Q, Yang NB, Mao Z, Zheng W, Wen YJ, Wang CY*.Impact of childhood trauma on sensory gating in patients with first-episode schizophrenia. BMC Psychiatry. 2018,18(1):258.SCI
18. Tang J, Fan Y#, Li H#, Xiang Q, Zhang DF, Li Z, He Y, Liao Y, Wang Y, He F, Zhang F, Shugart YY, Liu C, Tang Y*, Chan RCK*, Wang CY*, Yao YG*, Chen X*.Whole-genome sequencing of monozygotic twins discordant for schizophrenia indicates multiple genetic risk factors for schizophrenia. J Genet Genomics. 2017,44(6):295-306.SCI
19. Bo Q, Li F#, Li X, Wang Z, Dong F, He F, Li A, Ma X, Wang C*.Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study. Psychiatry Res. 2017,258:289-294.SCI
20. Yang NB, Tian Q#, Fan Y, Bo QJ, Zhang L, Li L, Wang CY*.Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition. BMC Psychiatry. 2017,17(1):135.SCI
21. Zhou FC, Wang CY#, Ungvari GS, Ng CH, Zhou Y, Zhang L, Zhou J, Shum DH, Man D, Liu DT, Li J, Xiang YT*.Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia. PLoS One. 2017,12(2):e**.SCI
22. Li XB, Bo QJ#, Zhang GP, Zheng W, Wang ZM, Li AN, Tian Q, Liu JT, Tang YL, Wang CY*.Effect of childhood trauma on cognitive functions in a sample of Chinese patients with schizophrenia. Compr Psychiatry. 2017,76:147-152.SCI
23. Bo QJ, Wang ZM#, Li XB, Ma X, Wang CY*, de Leon J.Adjunctive metformin for antipsychotic-induced hyperprolactinemia: A systematic review. Psychiatry Res. 2016,237:257-263.SCI
24. Ji S, Li A#, Wu K, Deng C, Dong F, Li L, Zhou T, Yue W, Wang CY*, Lu W*.Brief Questionnaire Derived from PANSS Using a General Probability Model to Assess and Monitor the Clinical Features of Schizophrenia. Pharmacopsychiatry. 2016,49(3):117-123.SCI
25. Ji S, Shang D, Wu K, Li A, Li X, Deng C, Li L, Zhou T, Wang C*, Lu W*.Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients. Int J Clin Pharmacol Ther. 2016,54(5):378-389.SCI
26. Ruan CJ, Li AN#, Dong F, Zhai YM, Li WB, Wang CY*, de Leon J.Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers. Clin Pharmacokinet. 2016,55(7):889-896.SCI
27. Bo Q, Dong F, Li X, Wang Z, Ma X, Wang C*.Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia. BMC Psychiatry. 2016,16(1):386.SCI
28. Man SC, Li XB#, Wang HH, Yuan HN, Wang HN, Zhang RG, Tan QR, Wong HK, McAlonan GM, Wang CY*, Zhang ZJ*.Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Women With Schizophrenia: A Randomized Controlled Trial. J Clin Psychopharmacol. 2016,36(6):572-579.SCI
29. Bo QJ, Li XB, Wang ZM, Li AN, Ma X, Wang CY*.Extrapyramidal Symptoms During Risperidone Maintenance Treatment in Schizophrenia: A Prospective, Multicenter Study. J Clin Psychopharmacol. 2016,36(2):125-129.SCI
30. Li AN, Dong F#, He JL, Shang DW, Guo W, Li WB, Lu W, Wang CY*.The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study. Pharmacopsychiatry. 2015,48(4-05):150-155.SCI
31. Li XB, Li QY, Liu JT, Zhang L, Tang YL, Wang CY*.Childhood trauma associates with clinical features of schizophrenia in a sample of Chinese inpatients. Psychiatry Res. 2015,228(3):702-707.SCI
32. Zheng W, Li XB#, Tang YL, Xiang YQ, Wang CY*, de Leon J.Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials. J Clin Psychopharmacol.. 2015,35(5):499-509.SCI
33. He F, Shao X#, Yi M, Wang Y, Wang CY*, Liu S*.Association of IL-1α rs17561 and IL-1 RN rs315952 polymorphisms with Tourette syndrome: a family-based study. Int J Clin Exp Pathol. 2015,8(4):4182-4185.SCI
34. Li XB, Tang YL, Wang CY*, de Leon J.Clozapine for treatment-resistant bipolar disorder: a systematic review. Bipolar Disord. 2015 May;17(3):235-47. Bipolar Disord. 2015,17(3):235-247.SCI
35. He F, Zheng Y, Huang HH, Cheng YH, Wang CY*.Association between Tourette Syndrome and the Dopamine D3 Receptor Gene Rs6280. Chin Med J (Engl). 2015,128(5):654-658.SCI
36. Xiang YT*, Li LJ#, Zhou JJ, Wang CY*, Dixon LB, Dickerson F, Zhou FC, Ungvari GS, Zhang XY, Shum DH, Au RW, Tang WK, Man D, Chiu HF.Quality of life of patients with euthymic bipolar disorder and its associations with demographic and clinical characteristics, psychopathology, and cognitive deficits. Perspect Psychiatr Care. 2014,50(1):44-50.SCI
37. Li X, Wang Z, Hou Y, Wang Y, Liu J*, Wang C*.Effects of childhood trauma on personality in a sample of Chinese adolescents. Child Abuse Negl. 2014,38（4）:788-796.SSCI
38. Li XB, Liu JT, Zhu XZ, Zhang L, Tang YL, Wang CY*.Childhood trauma associates with clinical features of bipolar disorder in a sample of Chinese patients. J Affect Disord. 2014,168:58-63.SCI
39. Zhou FC, Hou WM#, Wang CY*, Ungvari GS, Chiu HF, Correll CU, Shum DH, Man D, Liu DT, Xiang YT*.Prospective memory performance in non-psychotic first-degree relatives of patients with schizophrenia: a controlled study. PLoS One. 2014,9（11）:e111562.SCI
40. Wang ZM, Xiang YT*, An FR#, Correll CU, Ungvari GS, Wang CY*, Lai KY, Bo QJ, Li Y, Zhong BL, Chiu HF.Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in china. Perspect Psychiatr Care. 2014,50（4）:257-263.SCI
41. Wang Y, Yang Y, Hui L, Tie C, Li F, Xu ZQ*, Wang C*.A Neuropeptide Y Variant (rs16139) Associated with Major Depressive Disorder in Replicate Samples from Chinese Han Population. PLoS One. 2013,8(2):e57042.SCI
42. Li X, Tang Y, Wang C*.Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials. PLoS One. 2013,8(8):e70179.SCI
43. Zhou JJ, Xiang YT*, Wang CY*, Zhou FC, Ungvari GS, Dickerson F, Chiu HF, Lai KY, Shum DH, Lee E, Au RW, Tang WK, Man D.Prospective memory deficits in euthymic bipolar disorder patients: A preliminary study. Asia Pac Psychiatry. 2013,5(3):183-190.SCI
44. Wang YJ, Li H#, Yang YT, Tie CL, Li F, Xu ZQ*, Wang CY*.Association of galanin and major depressive disorder in the Chinese Han population. PLoS One. 2013,8(5): e64617.SCI
45. Li H, Wang YJ#, Hua L, Yang YT, Zhang M, Zhang D, Wang C*, Xu ZQ*.Lack of association between dendritic cell nuclear protein-1 gene and major depressive disorder in the Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry. 2013,45:7-10.SCI
46. Shang DW, Guo W, Zhou FC, Wang XP, Li AN, Zhang L, Li WB, Lu W*, Wang CY*.Relative Bioequivalence Evaluation of Two Oral Atomoxetine Hydrochloride Capsules: A Single Dose, Randomized, Open-Label, 2-Period Crossover Study in Healthy Chinese Volunteers under Fasting Conditions. Arzneimittelforschung （Drug Research）. 2013,63(11):564-567.SCI
47. Liu CH, Ma X, Li F, Wang YJ, Tie CL, Li SF, Chen TL, Fan TT, Zhang Y, Dong J, Yao L, Wu X*, Wang CY*.Regional Homogeneity within the Default Mode Network in Bipolar Depression: A Resting-State Functional Magnetic Resonance Imaging Study. PLoS One. 2012,7(11):e48181.SCI
48. Xiang YT, Wang Y, Wang CY*, Chiu HF, Chen Q, Chan SS, Lai KY, Lee EH, Ungvari GS.Association of insight with sociodemographic and clinical factors, quality of life, and cognition in Chinese patients with schizophrenia. Compr Psychiatry. 2012,53(2):140-144.SCI
49. Zhou FC, Xiang YT*, Wang CY*, Dickerson F, Au RW, Zhou JJ, Zhou Y, Shum DH, Chiu HF, Man D, Lee EH, Yu X, Chan RC, Ungvari GS.Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia. Schizophr Res. 2012,135(1-3):34-39.SCI
50. Li LJ, Shang DW#, Li WB, Guo W, Wang XP, Ren YP, Li AN, Fu PX, Ji SM, Lu W*, Wang CY*.Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia. Acta Pharmacol Sin. 2012,33(11):1409-1416.SCI
51. Liu CH, Li F, Li SF, Wang YJ, Tie CL, Wu HY, Zhou Z, Zhang D, Dong J, Yang Z*, Wang CY*.Abnormal baseline brain activity in bipolar depression: A resting state functional magnetic resonance imaging study. Psychiatry Res: Neuroimag. 2012,203(2-3):175-179.SCI
52. Xiang YT, Wang CY*, Chiu HF, Weng YZ, Bo QJ, Chan SS, Lee EH, Ungvari GS.Socio-Demographic and Clinical Profiles of Paranoid and Nonparanoid Schizophrenia: A Prospective, Multicenter Study in China. Perspect Psychiatr Care. 2011,47(3):126-130.SCI
53. 王传跃.精神分裂症研究的进展. 上海精神医学. 2011,23(4):196-198.核心期刊
54. Xiang YT, Wang CY*, Ungvari GS, Kreyenbuhl JA, Chiu HF, Lai KY, Lee EH, Bo QJ, Dixon LB.Weight Changes and their Associations with Demographic and Clinical Characteristics in Risperidone Maintenance Treatment for Schizophrenia. Pharmacopsychiatry. 2011,44(4):135-141.SCI
55. Xiang YT, Wang CY*, Weng YZ, Bo QJ, Chiu HF, Chan SS, Lee EH, Ungvari GS.Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study. Soc Psychiatry Psychiatr Epidemiol. 2011,46(12) :1325-1330.SCI
56. Wang CY, Xiang YT*, Weng YZ, Bo QJ, Chiu HF, Chan SS, Lee EH, Ungvari GS.Cigarette smoking in patients with schizophrenia in China: prospective, multicentre study. Australian and New Zealand Journal of Psychiatry. 2010,44(5):456-462.SCI
57. Xiang YT, Wang CY*, Weng YZ, Bo QJ, Chiu HF, Zhao JP, Liu TQ, Chan SS, Lee EH, Ungvari GS.Sex differences in patients with schizophrenia: A prospective, multi-center study. Psychiatry Research. 2010,177(3):294-298.SCI
58. Wang CY*, Xiang YT*, Cai ZJ, Weng YZ, Bo QJ, Zhao JP, Liu TQ, Wang GH, Weng SM, Zhang HY, Chen DF, Tang WK, Ungvari GS; For the Risperidone Maintenance Treatment in Schizophrenia (RMTS) investigators.Risperidone Maintenance Treatment in Schizophrenia: A Randomized, Controlled Trial. American Journal of Psychiatry. 2010,167(6):676-685.SCI
59. Xiang YT, Wang CY*, Wang Y, Chiu HF, Zhao JP, Chen Q, Chan SS, Lee EH, Ungvari GS.Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: a prospective study. Quality of Life Research. 2010,19(3):317-322.SCI
60. Yuan HN, Wang CY*, Sze CW, Tong Y, Tan QR, Feng XJ, Liu RM, Zhang JZ, Zhang YB, Zhang ZJ*.A Randomized Crossover Comparison of Herbal Medicine and Bromocriptine against Risperidone- Induced Hyperprolactinemia in Patients with Schizophrenia. Journal of Clinical Psychopharmacology. 2008,28(3):264-270.SCI
61. Xiang YQ, Zhang ZJ*, Weng YZ, Zhai YM, Li WB, Cai ZJ, Tan QR, Wang CY*.Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. Schizophrenia Research. 2006,83(2-3):201-210.SCI
62. Wang CY*, Zhang ZJ, Li WB, Cai ZJ, Weng YZ, Zhu RH, Zhao JP, Zhou HH.The Differential Effects of Steady-State Fluvoxamine on Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers. Journal of Clinical Pharmacology. 2004,44(7) :785-792.SCI
主编或副主编的著作/译著
1. 《精神药理学, 第2版》,副主编,人民卫生出版社,201611
2. 《精神科合理用药问答》,主编,人民卫生出版社,201111
3. 《精神药理学》,副主编,人民卫生出版社,200907
4. 《精神药物治疗学》,副主编,人民军医出版社,200505
重要奖项
1. 以神经软体征为核心的精神分裂症内表型研究 北京市科学技术奖 二等奖 201711
2. 中国医师协会精神科医师分会第六届中国杰出精神科医师奖 201704
3. 精神分裂症和抑郁症全病程规范化治疗和康复技术的研究及应用推广 北京市科学技术奖 三等奖 201412
4. 全国总工会2008年度全国知识型职工先进个人 200901
5. 中国医师协会第四届中国医师奖 200711